Background
- Experience
- professional experience. Mr. his career as a Process UTI Ultra Short Duration Fund – November 2025
Funds Abhishek Sonthalia manages
4Ranked by 3Y CAGR. Schemes without a three-year record yet are not listed. Open a fund for NAV history, rolling returns, risk metrics and peer rank.
| 1 | UTI - Credit Risk Fund. | ★☆☆☆☆ | +7.0% | +7.9% | +10.2% | 1.04% | ₹252.19Cr |
| 2 | UTI Short Duration Fund | ★★☆☆☆ | +5.7% | +7.5% | +7.6% | 0.41% | ₹2,444Cr |
| 3 | UTI Ultra Short Duration Fund | ★★★★★ | +6.6% | +7.3% | +7.1% | 0.40% | ₹3,810Cr |
| 4 | UTI Medium Duration Fund | ★☆☆☆☆ | +5.6% | +7.2% | +6.8% | 0.83% | ₹36.58Cr |
NAV data as of 21 Aug 2026. Role, qualifications and tenure are disclosures from UTI’s Scheme Information Documents and Statement of Additional Information — SEBI filings, not our assessment of anyone. 1 of the 4 scheme assignments come from another of the house’s filings naming them rather than from that scheme’s own document, so that list may be incomplete. Returns are computed from AMFI NAV history; see our methodology. A fund’s performance is not attributable to one person, and nothing here is investment advice.